دورية أكاديمية

P916: LONG‐TERM OUTCOMES WITH ISATUXIMAB‐CARFILZOMIB‐DEXAMETHASONE (ISA‐KD) IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH 1Q21+ STATUS: UPDATED RESULTS FROM THE PHASE 3 IKEMA STUDY.

التفاصيل البيبلوغرافية
العنوان: P916: LONG‐TERM OUTCOMES WITH ISATUXIMAB‐CARFILZOMIB‐DEXAMETHASONE (ISA‐KD) IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH 1Q21+ STATUS: UPDATED RESULTS FROM THE PHASE 3 IKEMA STUDY.
المؤلفون: Facon, Thierry, Moreau, Philippe, Špicka, Ivan, Suzuki, Kenshi, Yong, Kwee, Mikhael, Joseph, Fukao, Taro, Bisht, Kamlesh, Armstrong, Nicole, Macé, Sandrine, Risse, Marie‐Laure, Martin, Thomas
المصدر: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
قاعدة البيانات: Complementary Index
الوصف
تدمد:25729241
DOI:10.1097/01.HS9.0000970568.75232.84